# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Consortium Delivers Publicly Available Datasets that Enrich Detection of Rare and Novel Genetic Variants for Advances in Human ...
Jefferies analyst Tycho Peterson initiates coverage on Pacific Biosciences (NASDAQ:PACB) with a Buy rating and announces Pri...
Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced b...
Morgan Stanley analyst Tejas Savant maintains Pacific Biosciences (NASDAQ:PACB) with a Equal-Weight and lowers the price tar...
Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., along with PacBio (NASDAQ:P...